Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Amyloidogenic proteins in the SARS-CoV and SARS-CoV-2 proteomes

Journal article

Bhardwaj T. et al, (2023), Nature Communications

Potential of ADAM 17 Signal Peptide To Form Amyloid Aggregates in Vitro

Journal article

Bhardwaj T. and Giri R., (2023), ACS Chemical Neuroscience

Investigating the conformational dynamics of Zika virus NS4B protein.

Journal article

Bhardwaj T. et al, (2022), Virology, 575, 20 - 35

Reprofiling of approved drugs against SARS-CoV-2 main protease: an in-silico study.

Journal article

Kumar P. et al, (2022), J Biomol Struct Dyn, 40, 3170 - 3184

Role of structural disorder in the multi-functionality of flavivirus proteins.

Journal article

Kapuganti SK. et al, (2022), Expert Rev Proteomics, 19, 183 - 196

Mitoxantrone dihydrochloride, an FDA approved drug, binds with SARS-CoV-2 NSP1 C-terminal.

Journal article

Kumar P. et al, (2022), RSC Adv, 12, 5648 - 5655

The signal peptide of the amyloid precursor protein forms amyloid-like aggregates and enhances Aβ42 aggregation

Journal article

Gadhave K. et al, (2021), Cell Reports Physical Science, 2

Exploring the SARS-CoV-2 structural proteins for multi-epitope vaccine development: an in-silico approach.

Journal article

Kumar A. et al, (2020), Expert Rev Vaccines, 19, 887 - 898

Japanese encephalitis virus - exploring the dark proteome and disorder-function paradigm.

Journal article

Bhardwaj T. et al, (2020), FEBS J, 287, 3751 - 3776

Load More